Indocyanine green (ICG) fluorescence imaging is used in laparoscopic sleeve gastrectomy to evaluate gastric perfusion and support intraoperative decision-making. By providing real-time visualization of blood supply, this technique helps surgeons identify critical vascular structures and optimize staple line integrity.

In the EMEA region, standardized dosing and timing protocols aim to improve consistency in fluorescence imaging and enhance surgical safety. Although its routine use in bariatric surgery remains under evaluation, ICG has shown potential in assessing tissue perfusion and reducing ischemic complications.

Indocyanine green (ICG) fluorescence imaging is increasingly used in oesophagectomy to assess gastric conduit perfusion and guide anastomotic site selection. Adequate vascularization is critical, as poor perfusion is a major factor in anastomotic leak, one of the most serious postoperative complications.

In the EMEA region, standardized dosing and timing protocols help ensure consistent fluorescence imaging, supporting intraoperative decision-making and potentially reducing perfusion-related complications.

Indocyanine green (ICG) fluorescence imaging is increasingly used during esophagectomy to assess gastric conduit perfusion and support safe esophagogastric anastomosis. Near-infrared fluorescence angiography allows surgeons to visualize real-time blood flow to the gastric conduit, helping identify well-perfused tissue and reduce the risk of anastomotic complications.

This dosing and timing chart outlines recommended ICG administration for esophagectomy procedures, including intravenous injection protocols, dosage guidance, and expected fluorescence detection times to optimize intraoperative perfusion assessment during fluorescence-guided surgery.